Search

everythinglearnresearchcommunity

for

Search:↓

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Knuckle Acanthosis Nigricans is common in Latin American youth and may indicate early insulin resistance, especially in those with normal weight.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Teens with PCOS have a higher risk of type 2 diabetes and need regular glucose checks.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Hair conditions can be linked to diabetes and affect psychological health.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.